Journal article icon

Journal article

British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017

Abstract:

The overall aim of the guideline is to provide evidence-based recommendations on the use of biologic therapies (adalimumab, etanercept, infliximab, ixekizumab, secukinumab and ustekinumab) in adults, children and young people for the treatment of psoriasis; consideration is given to the specific needs of people with psoriasis and psoriatic arthritis. Biologic therapies have now been in use for over 10 years, and with accrued patient-years exposure and clinical experience, many areas that were...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1111/bjd.15665

Authors


More by this author
Role:
Author
ORCID:
0000-0001-9918-1144
More by this author
Role:
Author
ORCID:
0000-0003-4127-8263
More by this author
Role:
Author
ORCID:
0000-0002-1831-074X
Expand authors...
Guy's and St Thomas' NHS Foundation Trust More from this funder
King’s College London More from this funder
Publisher:
Wiley Publisher's website
Journal:
British Journal of Dermatology Journal website
Volume:
177
Issue:
3
Pages:
628-636
Publication date:
2017-05-17
Acceptance date:
2017-04-29
DOI:
EISSN:
1365-2133
ISSN:
0007-0963
Pmid:
28513835
Source identifiers:
695919
Language:
English
Keywords:
Pubs id:
pubs:695919
UUID:
uuid:3b4c5955-83c3-4139-b45a-361e7e50450a
Local pid:
pubs:695919
Deposit date:
2018-05-29

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP